Oruka Therapeutics, Inc. (ORKA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Oruka Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -13.11x | -3.89x | -55.08x | -41.29x | -18.57x | -23.28x |
| P/B Ratio | 2.93x | 0.85x | 7.94x | 9.83x | 7.03x | 4.87x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 22.37x | 28.89x | 59.01x | 37.72x | 15.56x | 14.28x |
| Quick Ratio | 22.37x | 28.89x | 59.01x | 37.72x | 15.56x | 14.28x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..